As a similarity, Ruiz-Cosano et al., following a study of 213 cases and 214 controls, reported that XPG 3507G>C polymorphism was not associated with the risk of lymphoma (OR = 1.1; 95% CI = 0.8–1.7) [66]. The gene discussed is ERCC5; the disease is lymphoma.